T-cell immunoglobulin and ITIM domains (TIGIT) is an inhibitory molecule expressed by lymphocytes that competes with the activating receptor DNAX accessory molecule-1 (DNAM-1) for binding to CD155 and CD112, which is expressed by myeloma cells and other cell types [9, 10]. This evidence concerns the gene CD226 and plasma cell myeloma.